The cloud solution targets pharmaceutical research and clinical development workflows.
Oracle Corporation has integrated real-world data, domain-trained artificial intelligence, and advanced analytics into its Oracle Life Sciences Data Intelligence platform. The cloud-native system incorporates Oracle Health Real-World Data, which includes more than 122 million de-identified longitudinal patient records as of May 2026.
The updated platform allows pharmaceutical researchers to use natural-language interactions to explore patient cohorts, conduct outcome analyses, and automate multistep research workflows. The tools support clinical trial recruitment, site optimization, health economics, market access, and evidence generation across the therapeutic lifecycle.
The platform combines customer proprietary data, third-party data, and Oracle Health records within a secure environment. It is built to integrate with Oracle's broader product ecosystem, including Oracle Cloud Infrastructure (OCI), Oracle Fusion Cloud applications, and Oracle Health solutions.
Newsletter
Markets in your inbox, weekly
Latin America-focused analysis, investment themes and the week in finance.
Keep reading